A Hochhaus
Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV
Miranda M, Neben K, Heinl C, Mahlberg R, Plöger C, Flasshove M, Rendenbach B, Hofmann W, Müller M, Pfirrmann M, Hochhaus A, Hasford J, Hehlmann R, Prümmer O, Fauser A, Verbeek W, Lauseker M, Kraus M, Proetel U, Hanfstein B, Fabarius A, Baerlocher G, Heim D, Hossfeld D, Kolb H, Krause S, Nerl C, Brümmendorf T, Saußele S. Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV. Leukemia 2016; 30:1255-62.
09.02.2016Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV
09.02.2016Leukemia 2016; 30:1255-62
Miranda M B, Neben K, Heinl Christina, Mahlberg R, Plöger C, Flasshove M, Rendenbach B, Hofmann W-K, Müller M C, Pfirrmann M, Hochhaus A, Hasford J, Hehlmann R, Prümmer O, Fauser A A, Verbeek W, Lauseker M, Kraus M-P, Proetel U, Hanfstein B, Fabarius A, Baerlocher G M, Heim D, Hossfeld D K, Kolb H-J, Krause S W, Nerl C, Brümmendorf T H, Saußele S
A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV
Steinbild S, Burkholder I, Edler L, Hanauske A, Hochhaus A, Strumberg D, Dittrich C, Gillessen Sommer S, Morant R, Frost A, Mross K, Scheulen M. A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV. British journal of cancer 2007; 97:1480-5.
03.12.2007A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV
03.12.2007British journal of cancer 2007; 97:1480-5
Steinbild S, Burkholder I, Edler L, Hanauske A-R, Hochhaus A, Strumberg D, Dittrich C, Gillessen Sommer Silke, Morant R, Frost A, Mross K, Scheulen M